Omic.ai
PrivateCompany Overview
Omic.ai is a biotechnology company that provides an AI-driven digital patient and multi-omics drug discovery platform for target identification, biomarker discovery, and generative compound screening.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, ML Platforms, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omic.ai Comparables
Compare Omic.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 82% | |
| Cellworks Group Inc | 81% | |
| Deep Origin | 80% | |
Omic.ai Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2025
Grew 100% QoQ from 13 to 26 employees.
- Jan 17, 2025
Grew 100% QoQ from 12 to 24 employees.
Omic.ai Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omic.ai's valuation, stock price, and market status.